Reassessing Patient Selection and Clinical Endpoints in Terlipressin Therapy for HRS‐AKI

Authors

Junbin Yan (ORCID: https://orcid.org/0000-0001-5014-7156)
Jinming Yu (ORCID: https://orcid.org/0009-0006-5449-2356)

Institutions

Zhejiang Chinese Medical University (CN)

Publication Details

Journal: Liver International
Published: 2025-11-29
DOI: https://doi.org/10.1111/liv.70467
Citations: 1
Primary Topic: Acute Kidney Injury Research
Type: article
Field-Weighted Citation Impact: 1.43

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Reassessing Patient Selection and Clinical Endpoints in Terlipressin Therapy for HRS‐AKI

Junbin Yan, Jinming Yu

Nov 29, 2025

1 citations

Liver International

Acute Kidney Injury Research

1.43

article

Reassessing Patient Selection and Clinical Endpoints in Terlipressin Therapy for HRS‐AKI

Junbin Yan, Jinming Yu

November 29, 2025article en

1 citations

Abstract

No abstract available for this paper.

Liver InternationalVol. 46(1)

Zhejiang Chinese Medical University (CN)

Openalex Percentile: Top 14%

Acute Kidney Injury Research

1.43

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Reassessing Patient Selection and Clinical Endpoints in Terlipressin Therapy for HRS‐AKI — Junbin Yan, Jinming Yu · Liver International (2025) | TGRS Research Map | TGRS